Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Granu Fink Prosta forte
- Development stage
- Unknown
- Lead developer
- Perrigo
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Granu Fink Prosta forte is a traditional herbal medicine (phytomedicine) containing a thick extract of pumpkin seeds (*Cucurbitae semen*). It is specifically indicated for the treatment of lower urinary tract symptoms (LUTS) in adult men, particularly those associated with benign prostatic hyperplasia (BPH) stages I to II (per Alken) or II to III (per Vahlensieck). The primary bioactive components are prostate-active Delta-7 sterols (Δ7-sterols), which exhibit structural similarities to the androgen dihydrotestosterone (DHT), allowing them to target the prostate/androgen signaling pathway. Marketed as hard capsules, the drug has been acknowledged by EAU Guidelines for long-term efficacy and has been evaluated in observational studies for its ability to improve symptoms such as frequent urination, nocturia, and weak urine stream.
- Brand names
- Granu Fink Prosta forte
- Other names
- pumpkin seed extractCucurbitae semen extract
02
Targets
SRD5A (Steroid 5-alpha-reductase)AR (Adrenergic receptors)
Beyond the preview
Go deeper on Granu Fink Prosta forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Granu Fink Prosta forte.